← Back
$PRCT All transactions

PROCEPT BioRobotics Corp

▲ BUY
9 / 10

Conviction

$ Value

$2.5M

Shares

106,554

Price

$23

Filed

Mar 9

Why this score? (9/10)
  • Open market buy (+3)
  • Trade value >= $1.0M (+2)
  • % of holdings >= 20% (+2)
  • Director (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Desai Antal Rohit

Title

CIK

0001881616

Roles

Director

Transaction Details

Transaction Date

2026-03-06

Code

P

Table

Non-Derivative

Ownership

Indirect

Equity Swap

No

Shares After

273,800

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.0645 to $26.0213, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. | CPMG, Inc. is the general partner and investment manager of Kestrel Fund, L.P. Antal Desai, a member of the Issuer's board of directors and a shareholder and managing partner of CPMG, Inc., may be deemed to share voting and investment power with respect to the shares beneficially owned by Kestrel Fund, L.P. Mr. Desai disclaims beneficial ownership of the shares beneficially owned by Kestrel Fund, L.P. except to the extent of any pecuniary interest therein. | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $26.10 to $26.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $22.785 to $23.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.79 to $24.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $23.40 to $24.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $24.40 to $25.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.40 to $25.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Filing Info

Accession No.

0000905148-26-001209

Form Type

4

Issuer CIK

0001588978

Desai Antal Rohit's History

Date Ticker Type Value
2026-03-09 PRCT $1.0M
2026-03-09 PRCT $1.3M
2026-03-09 PRCT $33K
2026-03-06 PRCT $2.5M
2026-03-06 PRCT $1.3M
2026-03-05 PRCT $3.6M
2026-03-05 PRCT $654K
2025-08-14 PRCT M $36K
2025-08-14 PRCT M $0
2025-06-12 PRCT $1.2M

Other Insiders at PRCT (90d)

Insider Bought Sold Last
Desai Antal Rohit $8.0M 2026-03-09
Wood Larry L
President, CEO
2026-03-05
Nouri Alaleh
EVP, CLO, CORP. SEC.
$394K 2026-03-19
PUCKETT DAN 2026-03-05
Waters Kevin
EVP, CFO
$179K 2026-03-17